bullish on cadila. target 600 - medium term
Grabbing the opportunity of producing the vaccine for covid for above 13 years age , the company has turned bullish. Seeing the fundamentals and growth rate , this is going to be the next sunpharma.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.